ABBOTT PARK, Ill. | Abbott has announced that the Xience Xpeditio Everolimus Eluting Coronary Stent System has received Health Canada approval and is launching immediately in Canada.
The Canadian Pharmacists Association (CPhA) is working on a report to ensure that pharmacy services are on the radar when the country’s provincial and territorial health ministers meet again in early October.